Get started
Author

Akira Kagayama

Observed names: A Kagayama, A. Kagayama, AKIRA KAGAYAMA, Akira KAGAYAMA
OpenAlex ID: A5068340697
Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans.
2001 · Y Naritomi, S Terashita, et al. · PubMed · 315
Utility of Hepatocytes in Predicting Drug Metabolism: Comparison of Hepatic Intrinsic Clearance in Rats and Humans in Vivo and in Vitro
2003 · Yoichi Naritomi, Shigeyuki Terashita, et al. · Drug Metabolism and Disposition · 189
Vibrational spectra and intermolecular potential of the α-form crystal of glycine
1977 · Katsunosuke Machida, Akira Kagayama, et al. · Spectrochimica Acta Part A Molecular Spectroscopy · 81
Prevention of progressive joint destruction in collagen‐induced arthritis in rats by a novel matrix metalloproteinase inhibitor, FR255031
2004 · Takeshi Ishikawa, Fusako Nishigaki, et al. · British Journal of Pharmacology · 59
PDF
Strategy for structural elucidation of drugs and drug metabolites using (MS)n fragmentation in an electrospray ion trap
2003 · Zenzaburo Tozuka, Hayato Kaneko, et al. · Journal of Mass Spectrometry · 58
PDF
Tissue Distribution after Intravenous Dosing of Micafungin, an Antifungal Drug, to Rats
2004 · Toshiro Niwa, Yoshiko Yokota, et al. · Biological and Pharmaceutical Bulletin · 54
PDF
Identification and relative contributions of human cytochrome P450 isoforms involved in the metabolism of glibenclamide and lansoprazole: evaluation of an approach based on thein vitrosubstrate disappearance rate
2004 · Y. Naritomi, S. Terashita, et al. · Xenobiotica · 52
Polarized Raman spectra and intermolecular potential of l-alanine crystal
1978 · Katsunosuke Machida, Akira Kagayama, et al. · Spectrochimica Acta Part A Molecular Spectroscopy · 51
Development of a Novel Drug Release System, Time-Controlled Explosion System(TES). II. Design of Multiparticulate TES and in Vitro Drug Release Properties.
1994 · Satoshi UEDA, Hisami YAMAGUCHI, et al. · Chemical and Pharmaceutical Bulletin · 49
PDF
Contribution of Human Hepatic Cytochrome P450 Isoforms to the Metabolism of Psychotropic Drugs
2005 · Toshiro Niwa, Toshifumi Shiraga, et al. · Biological and Pharmaceutical Bulletin · 48
PDF
Oral Absorption of FK506 in Rats
1993 · Akira Kagayama, Sachiyo Tanimoto, et al. · Pharmaceutical Research · 40
In vitroactivation of 7-benzyloxyresorufinO-debenzylation and nifedipine oxidation in human liver microsomes
2003 · T. Niwa, T. Shiraga, et al. · Xenobiotica · 39
Identification of Cytochrome P450 Enzymes Involved in the Metabolism of FK228, a Potent Histone Deacetylase Inhibitor, in Human Liver Microsomes
2005 · Toshifumi Shiraga, Zenzaburo Tozuka, et al. · Biological and Pharmaceutical Bulletin · 38
PDF
Utility of Microtiter Plate Assays for Human Cytochrome P450 Inhibition Studies in Drug Discovery: Application of Simple Method for Detecting Quasi-irreversible and Irreversible Inhibitors
2004 · Yoichi Naritomi, Yuriko Teramura, et al. · Drug Metabolism and Pharmacokinetics · 37
Osteotropic Drug Delivery System (ODDS) Based on Bisphosphonic Prodrug. I: Synthesis and in Vivo Characterization of Osteotropic Carboxyfluorescein
1995 · Jiro Fujisaki, Yuji Tokunaga, et al. · Journal of drug targeting · 30
Development of a novel drug delivery system, time-controlled explosion system (TES): V. Animal pharmacodynamic study and human bioavailability study
1994 · Takeshi Hata, Yasuo Shimazaki, et al. · International Journal of Pharmaceutics · 30
Investigation of the electrochemical oxidation products of zotepine and their fragmentation using on‐line electrochemistry/electrospray ionization mass spectrometry
2006 · Kazuyoshi Nozaki, Hiroshi Kitagawa, et al. · Journal of Mass Spectrometry · 28
Vibrational spectra and intermolecular potential of dl-serine crystal
1979 · Katsunosuke Machida, Mitsuo lzumi, et al. · Spectrochimica Acta Part A Molecular Spectroscopy · 28
Liposomal sustained-release delivery systems for intravenous injection. IV. Antitumor activity of newly synthesized lipophilic 1-.BETA.-D-arabinofuranosylcytosine prodrug-bearing liposomes.
1988 · YUJI TOKUNAGA, TOMOAKI IWASA, et al. · Chemical and Pharmaceutical Bulletin · 26
PDF
Polarized Raman spectra and intermolecular potential of DL ‐alanine crystal
1978 · Katsunosuke Machida, Akira Kagayama, et al. · Journal of Raman Spectroscopy · 25
Liposomal sustained-release delivery systems for intravenous injection. II. Design of liposome carriers and blood disposition of lipophilic mitomycin C prodrug-bearing liposomes.
1988 · YUJI TOKUNAGA, TOMOAKI IWASA, et al. · Chemical and Pharmaceutical Bulletin · 21
PDF
Polarized Raman spectra and intermolecular potential of α‐glycine‐C‐d2 and DL ‐alanine‐α,β‐d4 crystals
1979 · Katsunosuke Machida, Akira Kagayama, et al. · Journal of Raman Spectroscopy · 21
Liposomal sustained-release delivery systems for intravenous injection. I. Physicochemical and biological properties of newly synthesized lipophilic derivatives of mitomycin C.
1988 · YUJI TOKUNAGA, TOMOAKI IWASA, et al. · Chemical and Pharmaceutical Bulletin · 20
PDF
Mechanism of diffusion of compounds through ethylene vinyl acetate copolymers I. Kinetics of diffusion of l-chloro-4-nitrobenzene, 3,4-dimethylphenol and 4-hexylresorcinol
1984 · A. Kagayama, R. Mustafa, et al. · International Journal of Pharmaceutics · 19
Stereoselective Metabolism of Cibenzoline, an Antiarrhythmic Drug, by Human and Rat Liver Microsomes: Possible Involvement of CYP2D and CYP3A
2000 · Toshiro Niwa, Toshifumi Shiraga, et al. · Drug Metabolism and Disposition · 18
Works count: 50
Citation count: 1,588
H-index: 21
I10-index: 36
Year
Topic
Type